Article

Power adjustment at slit lamp: Pseudophakic light-adjustable IOL set to enter clinical trials

Orlando-A new light-adjustable IOL (LAL) has been designed that will allow for noninvasive correction of residual refractive errors present after cataract surgery, said Daniel M. Schwartz, MD, during the refractive surgery subspecialty day meeting prior to the annual meeting of the American Academy of Ophthalmology. Researchers are ready to begin testing the LAL in clinical trials, he added.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
© 2025 MJH Life Sciences

All rights reserved.